Asimov Announces Strategic Partnership with the Rosalind & Morris Goodman Cancer Institute at McGill University to Advance Next-Generation Biologics
Summary
Asimov formed a strategic partnership with McGill University’s Rosalind & Morris Goodman Cancer Institute to support next-generation biologics development. The company will provide cell line development and process development services for promising oncology molecules identified through the institute’s research programs. The collaboration gives McGill researchers access to Asimov’s CHO Edge System and Kernel software to improve manufacturability and cell line performance. The agreement targets a key bottleneck in advanced biologics: moving complex discoveries toward IND-enabling studies and clinical development.
Classifications
industries
Aerospace
applications
AI & Machine learning
AskAI Classifications
Labels
SaaS
Bioinformatics Software
Developer Tools
Linked Companies
Asimov
$1M to $5M